Zepp Health Shares Sink 19.11% After $51.5 Million Q1 as Balance Sheet Worries Eclipse Growth
Updated
Updated · the5krunner.com · Jun 9
Zepp Health Shares Sink 19.11% After $51.5 Million Q1 as Balance Sheet Worries Eclipse Growth
1 articles · Updated · the5krunner.com · Jun 9
Summary
ZEPP fell 19.11% over five days even after Zepp posted record Q1 revenue of $51.5 million, up 33.8%, with gross profit rising 35.3% to $19.4 million.
A $35 million gap between current liabilities and current assets, plus nearly doubled short-term borrowings, appeared to drive the selloff despite management saying the debt shift was largely a reclassification and cash stood at $103.2 million.
Profitability also remained in doubt: GAAP net loss was $19.6 million, and Q2 revenue guidance of $63 million-$68 million sits below the $75.8 million level where Zepp last reached adjusted operating breakeven in Q3 2025.
Margins added pressure, with gross margin slipping to 37.7% from 40.4% in Q4 as lower-margin entry models refreshed and memory costs rose during the DDR4-to-DDR5 transition.
Zepp is betting on a stronger second half through 10 or more 2026 launches and higher pricing, but investors appear to want several consecutive breakeven quarters before rewarding the strategy.